Research & Innovation

Projects

The Institut de Recerca Sant Pau develops research projects across multiple scientific areas, with the aim of generating innovative knowledge that has an impact on health. Through national and international collaborations, these projects contribute to scientific progress and the improvement of healthcare.

Sort
Search Bar
Active CP24/00112-P Proj. Assoc. a Contractes d'Investigadors Miguel Servet 2024
Start Date: 2025-01-01
End Date: 2028-12-31
Amount: 40.000,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Active FUND. LUZON 2024 Assessing the role of CSF immune cells in ALS
Start Date: 2024-11-01
End Date: 2027-10-31
Amount: 158.960,00 €
Funding body: FUNDACION LUZON
Active HEAD Longitudinal multicenter head-to-head harmonization of tau PET tracers
Start Date: 2024-06-01
End Date: 2026-12-31
Amount: 36.831,65 €
Funding body: NATIONAL INSTITUTE OF HEALTH
Active FUNDELA 2024 Caracterización del papel de las células Natural Killer y sus exosomas en la ELA
Start Date: 2024-09-01
End Date: 2026-12-31
Amount: 69.850,00 €
Funding body: FUNDACION FUNDELA
Active 2326 2024a Reduced Learning Over Repeated Exposures and its Association with Preclinical Alzheimer's Disease in Down Syndrome: A Novel Digitalized Outcome Measure for Preventive Clinical Trials
Start Date: 2024-10-01
End Date: 2026-10-01
Amount: 3.998,80 €
Funding body: FONDATION JEROME LEJEUNE
Active AC24/00133 Mecanismos de vulnerabilidad de interneuronas parvalbumina dependientes de sexo en la enfermedad de Alzheimer
Start Date: 2025-01-01
End Date: 2027-12-31
Amount: 155.000,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Active 2024-2245 The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome
Start Date: 2025-02-18
End Date: 2029-07-31
Amount: 91.918,40 €
Funding body: NATIONAL INSTITUTE OF HEALTH
Active PI25/00422 Agregación de alfa-sinucleína en LCR y vesículas extracelulares neuronales: Asociación con neuropatología cortical y correlatos clínicos.
Start Date: 2026-01-01
End Date: 2028-12-31
Amount: 183.937,96 €
Funding body: INSTITUTO DE SALUD CARLOS III
Active AACSF-25-1486364 Alpha-Synuclein Seed Amplification Assay: Validation and Kinetics Analysis
Start Date: 2025-10-01
End Date: 2028-12-31
Amount: 196.622,00 €
Funding body: ALZHEIMER'S ASSOCIATION
Active AFTD-GC Magnetic Resonance Imaging and Extracellular Vesicle tau as Diagnostic and Prognostic Biomarkers in 4R-tauopathies
Start Date: 2026-02-01
End Date: 2028-06-30
Amount: 127.280,00 €
Funding body: ASS.FRONTOTEMPORAL DEGENERATI
Active PID2021-124411OB-I00 La Sobre-activación de Camk2 Sustentaría las Disfunciones Sinápticas Observadas en la Encefalopatía Epiléptica SYNGAP1
Start Date: 2022-09-01
End Date: 2026-08-31
Amount: 181.500,00 €
Funding body: MIN.CIENCIA, INNOV.I UNIV.
Active RED2024-154082-T Red para el estudio integrativo de circuitos sinápticos y su rol en enfermedad
Start Date: 2025-05-01
End Date: 2027-04-30
Amount: 28.000,00 €
Funding body: MIN.CIENCIA, INNOV.I UNIV.
Active PID2024-160538OB-I00 Explorando las Sinapsis y las Oscilaciones Cerebrales: Nuevas Estrategias Terapéuticas en los Trastornos Relacionados con SYNGAP1
Start Date: 2025-09-01
End Date: 2028-08-31
Amount: 250.000,00 €
Funding body: MIN.CIENCIA, INNOV.I UNIV.
Active NIH-WS-ISRAEL Genetic Architecture of Cerebral Edema after Stroke
Start Date: 2022-11-29
End Date: 2027-05-31
Amount: 6.394,07 €
Funding body: NATIONAL INSTITUTE OF HEALTH
Active MARATO 202310-30 Stopped-Stroke. Reversible epigenetic therapies to SToP biological age and reduce STroke risk.
Start Date: 2024-04-22
End Date: 2027-04-21
Amount: 133.972,50 €
Funding body: FUNDACIO LA MARATO DE TV3
Active MARATO 202306-30 Gen-X project: Genetic and epigenetic study of ischemic stroke and its sex differences
Start Date: 2024-03-20
End Date: 2027-03-19
Amount: 199.801,25 €
Funding body: FUNDACIO LA MARATO DE TV3
Active AC23_2/00041 CADASIL-Historia Natural (CADANHIS)
Start Date: 2024-01-01
End Date: 2026-12-31
Amount: 179.375,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Active PI24/02102 PROMETEO: Estudio Proteo-genómico y de integrómica de datos para identificar tratamientos que mejoren la evolución neurológica del ictus
Start Date: 2025-01-01
End Date: 2027-12-31
Amount: 196.250,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Active CPP2023-010519 Evaluación de la eficacia de la leriglitazona y búsqueda de potenciales biomarcadores en enfermedades de la sustancia blanca
Start Date: 2024-06-01
End Date: 2027-05-31
Amount: 331.125,64 €
Funding body: MIN.CIENCIA, INNOV.I UNIV.
Active PI25/01351 Proyecto NeuroG3n. Integración de Genómica 3D y Accesibilidad de la Cromatina para Identificar Mecanismos Genéticos del Deterioro Neurológico Post-Ictus.
Start Date: 2026-01-01
End Date: 2028-12-31
Amount: 178.625,00 €
Funding body: INSTITUTO DE SALUD CARLOS III